At a glittering event, the best performers in the credit management sector were honoured at the Irish Credit Teams Awards ...

Grifols rejects Brookfield’s €10.5/share offer, signaling undervaluation. Read why GRFS stock is a strong "Buy" despite the ...

On Wednesday, Grifols SA (NASDAQ:GRFS) said it ended discussions with Brookfield Capital Partners (UK) Limited about a ...

Grifols (NASDAQ:GRFS) has commenced discussions with banks to refinance its bonds due in 2025, Bloomberg News reported, a day ...

The funds will help Cradle scale its operations to accelerate the adoption of its core product --- an AI-powered protein ...

The Spanish pharmaceutical company said it considered Brookfield’s offer of 10.50 euros a share undervalued the company and ...

Shares of Grifols GRFS lost over 7% on Wednesday after the company announced that Canada-based Brookfield Asset Management ...

基立福（Grifols）近日在西班牙的股票交易中遭遇重创，股价跌幅扩大至10%，刷新了每日最低记录。这一显著下滑反映出投资者对该公司前景的忧虑，尤其是在当前全球医药市场愈发动荡的背景下。

The board of Spanish plasma-based medicines producer Grifols has announced the termination of discussions with Brookfield ...

For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...

The Canadian fund Brookfield has decided to withdraw its interest in a public exclusion offer to acquire Grifols due to ...

Barcelona-based Grifols has seen its stock value plummet since January, when short seller Gotham City Research accused the company of manipulating debt and earnings reporting by consolidating profit ...